Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Gastroenterology. 2021 Sep 3;161(6):1887–1895.e4. doi: 10.1053/j.gastro.2021.08.050

Table 2.

Reclassification of liver transplant candidates between MELDNa and MELD3.0 in the validation set. (A) the number of patients, (B) the number of deaths and (C) the proportion of death (B divided by A). Red-demarcated areas indicate up-scoring (MELD3.0 category higher than MELDNa) and blue-demarcated areas the opposite.

A. Patients (n) MELD 3.0
6–9 10–19 20–29 30–39 40+
MELDNa 6–9 1047 334 - - -
10–19 66 3093 341 - -
20–29 - 150 2182 140 -
30–39 - - 64 1007 75
40+ - - - 26 298
B. Deaths (n) MELD 3.0
6–9 10–19 20–29 30–39 40+
MELDNa 6–9 6 4 - - -
10–19 - 45 16 - -
20–29 - 6 166 23 -
30–39 - - 8 141 19
40+ - - - 3 77
C. Death (%) MELD 3.0
6–9 10–19 20–29 30–39 40+
MELDNa 6–9 0.6% 1.2% - - -
10–19 - 1.5% 4.7% - -
20–29 - 4.0% 7.6% 16.4% -
30–39 - - 12.5% 14.0% 25.3%
40+ - - - 11.5% 25.8%